Julianne Bruno

Vice President at CRISPR Therapeutics - Program Lead Immune-Oncology, Hemoglobinopathy; Head of Program Mgmt

Julianne Bruno is a highly accomplished professional with a strong background in business economics, public policy, and the healthcare industry.

She holds a Master of Business Administration (MBA) degree in Business Economics & Public Policy from Wharton Business School and a Bachelor of Arts (B.A.) degree in Woodrow Wilson School of Public and International Affairs from Princeton University.

Julianne has held significant leadership roles at CRISPR Therapeutics, where she served as Vice President, Executive Director, Senior Director, and Director, showcasing her expertise in the biotechnology sector.

Prior to her tenure at CRISPR Therapeutics, she gained valuable experience at McKinsey & Company as an Engagement Manager and Associate, focusing on strategic consulting.

Julianne's professional journey also includes roles in global health at BD, the Office of the Chief of Staff at Robin Hood, and as Vice President at JPMorgan Chase.

Her diverse experience across various organizations highlights her versatile skill set and ability to excel in dynamic environments.